New Brunswick should save money by speeding up approval of generic drugsProvince’s pharmacists’ association president says province should automatically approve generic equivalents to their formularies after Health Canada has okayed them. Poor prognosis seen in cerebral bleeds despite treatmentWarfarin antidote deemed necessary but not sufficient Wean patients off low-dose ASA if they don't have cardiovascular disease: Researchers Pharmacy steps up for World Diabetes Day Banners, organizations remind Canadians that diabetes resources, education are as close as their local pharmacy. New Brunswick and P.E.I.’s wait for catastrophic coverage criticized Government taking wrong approach to creating catastrophic drug program, health society says. OxyNeo to replace pain product Product will be replacing OxyContin with a new tamper-resistant oxycodone Sublinox: new non-benzodiazepine hypnotic coming soon Drug is indicated for the short-term treatment, symptomatic relief of insomnia. Mobile personal health record launched in Canada MiHealth is the brainchild of Ontario’s Dr. Wendy Graham Congenital toxoplasmosis has more severe signs in U.S. versus Europe U.S. researcher calls for universal testing in pregnancy, but Canadian disagrees Depression wracking young diabetes patients But evidence is thin that treating depression helps improve cardiovascular and other diabetic outcomes Health Canada reports five mix ups involving the drugs Pradax and Plavix Drugmakers for the two products team up with Health Canada to alert patients of the risk of medication errors associated with name confusion. Less is more for FSH in anovulatory infertility Fewer cancellations with smaller incremental boosts of hormone First Previous 855 856 857 858 859 Next Last
